Coraline D. P.
- Country
- France
- Department
- Service de Gynecologie et du Sein
Research Overview
- Phase I Safety Run‑In and Phase II Efficacy Study of Ubamatamab in Combination Therapy as Salvage Treatment for Poor‑Response Ovarian Cancer
- A Phase 3, Randomized, Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab With or Without Bevacizumab Compared With Standard of Care as Firstline Maintenance Treatment for Participants With Persistent, Recurrent, or Newly Diagnosed Metastatic Cervical Cancer With PD-L1 CPS Greater Than or Equal to 1 (TroFuse-036/GOG-3123/ENGOT-cx22)
Data & Insights
Has run more than one trial at 3 of 69 partner sites.
Specializations
Gynecologic Oncology
The investigator focuses on malignancies of the female reproductive system, including cancers of the uterus, cervix, ovary, fallopian tube, and peritoneum.
- Advanced Endometrial Cancer
- High‑grade Serous Ovarian Cancer
- Fallopian Tube Carcinoma
- Primary Peritoneal Carcinoma
- Cervical Squamous Cell Carcinoma
Research includes both early‑stage and metastatic disease settings.
Breast Oncology
Extensive work on hormone‑responsive and HER2‑targeted breast malignancies across the disease continuum.
- Hormone Receptor‑Positive, HER2‑Negative Breast Cancer
- HER2‑Positive Metastatic Breast Cancer
- Triple‑Negative Breast Cancer
- Early‑stage Luminal A Breast Cancer
- Breast Cancer with Brain Metastasis
Emphasis on targeted therapies and biomarker‑driven strategies.
Head and Neck & Salivary Gland Tumors
Investigation of malignancies arising in the upper aerodigestive tract and major salivary glands.
- Head and Neck Squamous Cell Carcinoma
- Carcinoma of Major Salivary Glands
- Recurrent Sinonasal Tumors
- Adenoid Cystic Carcinoma of the Head and Neck
- Resected Sinonasal Tumors
Includes both operable and non‑operable disease cohorts.
Genitourinary & Renal Cancers
Focus on malignancies of the urinary system and kidney, including prostate and renal cell carcinoma subtypes.
- Metastatic Castration‑Resistant Prostate Cancer
- Hormone‑Sensitive Prostate Cancer
- Clear Cell Renal Cell Carcinoma
- Non‑Clear Cell Renal Cell Carcinoma
- Urothelial Carcinoma
Research addresses both biomarker‑selected and broad patient populations.
Thoracic Oncology
Engagement with a spectrum of non‑small cell lung cancer entities and related thoracic malignancies.
- Advanced Non‑Small Cell Lung Cancer
- ALK‑Positive NSCLC
- EGFR‑Mutated NSCLC
- MET‑Altered NSCLC
- Small Cell Lung Cancer
Studies span first‑line to refractory disease contexts.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.